REG - Science in Sport PLC - Restoration of Trading & Posting of Annual Report

Science in SportAnnouncement

04/07/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230704:nRSD8875Ea&default-theme=true

RNS Number : 8875E  Science in Sport PLC  04 July 2023

4 July 2023

Science in Sport plc

("Science in Sport", "the Company" or the "Group")

 

Restoration of Trading

and

Posting of Annual Report

Science in Sport plc (AIM: SIS), the premium performance nutrition company
serving elite athletes, sports enthusiasts, and the active lifestyle
community, announces that its ordinary shares are due to be restored to
trading on AIM at 7.30 a.m. today, following the publication of its audited
accounts for the year ended 31 December 2022.

The Company's Annual Report and Accounts for the year ended 31 December 2022
have been posted to shareholders and are available on the Company's website,
at www.sisplc.com/results-centre/.

For further information please contact:

For further information:

 Science in Sport plc                     T: 020 7400 3700
 Stephen Moon, CEO

 Daniel Lampard, CFO

 Liberum (Nominated Adviser and Broker)   T: 020 3100 2000
 Richard Lindley

 William Hall

 Lucas Bamber

 

Notes to Editors

About Science in Sport plc

Headquartered in London, Science in Sport plc is a leading sports nutrition
business that develops, manufactures, and markets innovative nutrition
products for professional athletes, sports and fitness enthusiasts and the
active lifestyle community. The Company has two highly regarded brands, PhD
Nutrition, a premium active-nutrition brand targeting the active lifestyle
community, and SiS, a leading endurance nutrition brand among elite athletes
and professional sports teams.

The two brands sell through the Company's phd.com and scienceinsport.com
digital platforms, third-party online sites, including Amazon and Tmall, and
extensive retail distribution in the UK and internationally, including major
supermarkets, high street chains and specialist sports retailers. This
omnichannel footprint enables the Company to address the full breadth of the
sports nutrition market, sports nutrition market, worth $24.6bn in 2022 and
forecast to grow CAGR 5.9% from 2022 to 2027.(1)

PhD is one of the UK's leading active nutrition brands with a reputation for
high quality and product innovation. The brand has grown rapidly since its
launch in 2005. The range now comprises powders, bars, and supplements,
including the high protein, low sugar range, PhD Smart. PhD brand ambassadors
include leading endurance and strength athlete Ross Edgley and influencer
Gabby Allen.

SiS, a leading endurance nutrition business founded in 1992, has a core range
comprising gels, powders and bars focused on energy, hydration, and recovery.
SiS is an official endurance nutrition supplier to over 320 professional
teams, organisations, and national teams worldwide. SiS supplies more than 150
professional football clubs in the UK, Europe, and the USA.

SiS is Performance Solutions partner to Ineos Grenadiers cycling team, and
Tottenham Hotspur and CGC Nice football clubs, as well as Official Nutrition
Partner to the Milwaukee Bucks, 2021 National Basketball Association
Champions.

For further information, please visit phd.com and scienceinsport.com

 

(1 )Euromonitor Passport Database Global Assessment (October 2022)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCRIMITMTAMMRJ